Men's Kirkland Extra Strength 5% Unscented Solution Carton

Manufacturer
Costco Wholesale Corporation
Effective date
2010-08-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:25:52

Label at a glance#

ProductMens Kirkland Extra Strength
Active ingredientMinoxidil
Label structure10 sections

Dosage and administration

apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area using more or more often will not improve results continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again

Storage and handling

see hair loss pictures on side of this carton before use, read all information on carton and enclosed booklet keep the carton. It contains important information. hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with 5% minoxidil topical solution for men in clinical studies with mostly white men aged 18-49 years with moderate degrees of hair loss, 5% m...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Minoxidil 5% w/v

Purpose

OTC - PURPOSE SECTION

Hair regrowth treatment for men

Use

INDICATIONS & USAGE SECTION

to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)

Warnings

WARNINGS SECTION

For external use only. For use by men only.

Flammable: Keep away from fire or flame

OTC - DO NOT USE SECTION

Do not use if

  • you are a woman
  • your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp. 5% minoxidil topical solution is not intended for frontal baldness or receding hairline.
  • you have no family history of hair loss
  • your hair loss is sudden and/or patchy
  • you do not know the reason for your hair loss
  • you are under 18 years of age. Do not use on babies and children.
  • your scalp is red, inflamed, infected, irritated, or painful
  • you use other medicines on the scalp

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have heart disease

OTC - WHEN USING SECTION

When using this product

  • do not apply on other parts of the body
  • avoid contact with the eyes. In case of accidental contact, rinse eyes with large amounts of cool tap water.
  • some people have experienced changes in hair color and/or texture
  • it takes time to regrow hair. Results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results.
  • the amount of hair regrowth is different for each person. This product will not work for all men.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • chest pain, rapid heartbeat, faintness, or dizziness occurs
  • sudden, unexplained weight gain occurs
  • your hands or feet swell
  • scalp irritation or redness occurs
  • unwanted facial hair growth occurs
  • you do not see hair regrowth in 4 months

OTC - PREGNANCY OR BREAST FEEDING SECTION

May be harmful if used when pregnant or breast-feeding.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area
  • using more or more often will not improve results
  • continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again

Other information

STORAGE AND HANDLING SECTION

  • see hair loss pictures on side of this carton
  • before use, read all information on carton and enclosed booklet
  • keep the carton. It contains important information.
  • hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with 5% minoxidil topical solution for men
  • in clinical studies with mostly white men aged 18-49 years with moderate degrees of hair loss, 5% minoxidil topical solution for men provided more hair regrowth than 2% minoxidil topical solution
  • store at controlled room temperature 20° to 25° C (68° to 77° F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

alcohol, propylene glycol, purified water

Questions?

OTC - QUESTIONS SECTION

  • call us at 1-877-907-6424

PRINCIPAL DISPLAY PANEL - 60 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

KIRKLAND
Signature™

MINOXIDIL
EXTRA STRENGTH FOR MEN

5% MINOXIDIL TOPICAL SOLUTION

HAIR REGROWTH
TREATMENT

Regrows
more hair than
2% Minoxidil
Topical Solution

Results may occur at 2 months

NOT FOR USE BY WOMEN

Unscented

3-60 mL (2 fl oz) Bottles

Principal Display Panel - 60 mL Bottle Carton
Principal Display Panel - 60 mL Bottle Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
311724minoxidil 5 % Topical SolutionPSN1
311724minoxidil 50 MG/ML Topical SolutionSCD1
311724minoxidil 3 GM per 60 ML Topical SolutionSY1
311724minoxidil 5 % Topical SolutionSY1
311724minoxidil 5 GM per 100 ML Topical SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MINOXIDIL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63981-111-012020-01-31C16284748780-19d75b9d0-3034-f424-e053-dadaa90a57ceMen's Kirkland Extra Strength 5% Unscented Solution Carton

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63981-111-01Mens Kirkland Extra Strength12 in 1 TRAYSOLUTION121
63981-111-01Mens Kirkland Extra Strength2 in 1 PACKAGE, COMBINATIONSOLUTION21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63981-111MENS KIRKLAND (MINOXIDIL) SOLUTION [COSTCO WHOLESALE CORPORATION]1Legacy NDC, 2 package rows20100921_ee71efe1-2505-4e9e-b1aa-ae8b6463596b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MinoxidilACTIVE INGREDIENT5965120SH11
MinoxidilACTIVE MOIETY5965120SH11
alcoholINACTIVE INGREDIENT3K9958V90M1
propylene glycolINACTIVE INGREDIENT6DC9Q167V31
waterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63981-11163981-111-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 140 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
alcoholALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION, EMULSION / INTRAVENOUS520 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3LIQUID / RESPIRATORY (INHALATION)10 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3GEL / TRANSDERMAL500 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SPONGE / TOPICAL40 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3LIQUID / ORAL29008 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLIQUID / INTRAVENOUS400 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CREAM / VAGINAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / TOPICAL5.28 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3LOTION / TOPICAL3392 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSYRUP / ORAL21000 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL / NASAL20 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLOTION / TOPICAL25 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CREAM, AUGMENTED / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAVENOUS4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION, SOLUTION / SUBCUTANEOUS6.1 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL, METERED / TRANSDERMAL3675 mgExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MMOUTHWASH / BUCCAL200 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / RECTAL1214 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CAPSULE / ORAL1072 mgExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, SPRAY / RESPIRATORY (INHALATION)35.75 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / INTRAMUSCULAR1491 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MPASTE / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MTABLET, DELAYED RELEASE / ORALNAExact identifier — unii candidate
59 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)MINOXIDIL5%SOLUTION / TOPICALRLD, RS1997-11-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1484e616aacf4f…
2026-08-18 06:07:402026-07N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-148072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-145c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-145d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-144b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-1487673890dc5c…
2021-03-12 10:30 UTC2021-03N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-145aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-148869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-143f01610625f2…
2019-09-15 20:21 UTC2019-09N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14b00525d2431f…
2019-07-19 19:46 UTC2019-07N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-146a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-141c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-149b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-143f0d92c62455…
2023-05-13 08:27 UTC2023-05N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14053a50430f4f…
2023-01-26 05:58 UTC2023-01N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-143bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-143a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020834-001ROGAINE EXTRA STRENGTH (FOR MEN)5%SOLUTION / TOPICALRLD, RS1997-11-14f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fc4ad05c-3d62-4450-8fad-95f1d4ffdc29ee71efe1-2505-4e9e-b1aa-ae8b6463596b2010-08-20WarningsExact identifier
spl id: fc4ad05c-3d62-4450-8fad-95f1d4ffdc29
spl set id: ee71efe1-2505-4e9e-b1aa-ae8b6463596b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.